Management of Cannabinoid Hyperemesis Syndrome
The cornerstone of CHS management is complete cannabis cessation, which is the only definitive cure; for acute symptom control, use topical capsaicin cream (0.1%) or haloperidol, while avoiding opioids entirely due to worsening nausea and addiction risk. 1
Acute Management (Emergency Department Setting)
First-Line Acute Therapies
The evidence supports several options for immediate symptom relief, though the data comes primarily from case series and small trials 1:
Topical capsaicin (0.1% cream): Apply approximately 2 grams across the abdomen. Expect an acute burning sensation for 15-30 minutes, but vomiting typically ceases within 10 minutes and pain resolves by 90 minutes. This works by activating TRPV1 receptors, mimicking the hot-water bathing effect that patients instinctively seek 1, 2
Haloperidol: Administer 5 mg intramuscularly for rapid antiemetic effect 1, 3
Alternative antiemetics with supporting evidence include: benzodiazepines, droperidol, promethazine, olanzapine, and ondansetron 1
Critical Pitfall to Avoid
Never use opioids - they worsen nausea and carry high addiction risk in this population 1, 4. Standard antiemetics like ondansetron and metoclopramide frequently fail in CHS 4, 2.
Essential ED Evaluation
Before diagnosing CHS, you must exclude life-threatening conditions: acute abdomen, bowel obstruction, mesenteric ischemia, pancreatitis, and myocardial infarction 1. Look for metabolic derangements from severe vomiting - hypokalemic hypochloremic metabolic alkalosis and prerenal azotemia are common 2.
Long-Term Management (Outpatient Setting)
Definitive Treatment
Cannabis cessation is non-negotiable - symptoms resolve only after at least 6 months of complete abstinence, or a duration equal to 3 typical vomiting cycles 1. Without cessation, recidivism rates are extremely high 1.
Pharmacologic Bridge Therapy
While working toward cessation, use amitriptyline as the mainstay:
- Start at 25 mg at bedtime
- Titrate weekly by 25 mg increments
- Target dose: 75-100 mg at bedtime 1
Adjunctive Strategies
Topical capsaicin (0.1%) cream can be prescribed for home use during prodromal symptoms, with close monitoring for efficacy and adverse effects 1
Psychosocial interventions are essential - combine evidence-based counseling with pharmacotherapy for successful long-term management 1
Co-management with psychiatry/psychology is warranted for patients with treatment-refractory symptoms or significant psychiatric comorbidity, as anxiety and depression are very common 1
Diagnostic Confirmation
CHS diagnosis requires three elements 1:
Clinical features: Stereotypical episodic vomiting resembling cyclic vomiting syndrome, occurring ≥3 times annually
Cannabis use pattern:
- Duration >1 year before symptom onset
- Frequency >4 times per week on average
- Often daily or multiple times daily 1
Cannabis cessation: Complete symptom resolution after ≥6 months abstinence
Key Clinical Clue
Hot-water bathing behavior (prolonged hot baths/showers) occurs in 71% of CHS patients 1. While not pathognomonic (also seen in cyclic vomiting syndrome), it strongly suggests CHS in the context of chronic cannabis use.
Important Nuances
Strategies lacking scientific validation that you should not recommend: switching to lower THC/higher CBD formulations, using edible forms instead of smoking, or avoiding THC concentrates 1. These do not address the underlying problem.
Patient education challenge: Many patients remain uncertain about cannabis's role even after diagnosis, attributing symptoms to food, alcohol, stress, or other GI disorders 1. Direct, clear counseling about the causal relationship is essential.
The differential diagnosis after excluding structural abnormalities includes rumination syndrome, gastroparesis, cyclic vomiting syndrome, pregnancy, migraine, and functional chronic nausea and vomiting syndrome 1.